Albumin Market Size to Surpass USD 8.76 Billion by 2030, at a CAGR of 4.7%
November 28, 2023 08:14 ET
|
Fortune Business Insights
Pune, India, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The albumin market size was valued at USD 6.14 billion in 2022 and is expected to be worth USD 6.35 billion in 2023. The market is projected to reach...
Albumin Market Poised for Robust Growth at a CAGR of 6.4% to Reach US$ 7.3 Billion by 2030, Driven by Therapeutic Applications and Expanding Non-Therapeutic Uses
November 23, 2023 08:45 ET
|
Rationalstat LLC
Wilmington, Delaware, Nov. 23, 2023 (GLOBE NEWSWIRE) -- According to RationalStat’s market study, the Global Albumin Market value is estimated at US$ 4.7 billion in 2023 and is expected to rise at a...
Global $5.56 Bn Darbepoetin Alfa (Epogen, Procrit, Aranesp) Market Analysis & Forecasts, 2017-2022, 2022-2027F, 2032F
October 17, 2023 03:33 ET
|
Research and Markets
Dublin, Oct. 17, 2023 (GLOBE NEWSWIRE) -- The "Darbepoetin Alfa (Aranesp) Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.The global darbepoetin alfa (Aranesp)...
Dyadic to Present at Industry and Investor Events in October
September 29, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic to Present at Industry and Investor Events in October
Critical Care Application Dominates the Global Plasma Fractionation Market, Fueled by Increasing Utilization of Immunoglobulins
September 28, 2023 07:48 ET
|
Research and Markets
Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology,...
Dyadic Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
August 09, 2023 16:00 ET
|
Dyadic International, Inc.
Positive Interim Phase 1 clinical trial safety results for C1 platform for manufacturing human vaccines Two MoU’s with Fondazione Biotecnopolo di Siena in Italy and Essential Drugs Company Limited...
Dyadic Announces Continued Progress Towards Commercialization of Animal-Free Recombinant Serum Albumin
August 07, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Plasma Fractionation Market revenue to exceed USD 37 Billion by 2033, says Research Nester
July 31, 2023 06:00 ET
|
Research Nester
New York, July 31, 2023 (GLOBE NEWSWIRE) -- The global plasma fractionation market size is slated to expand at ~7% CAGR between 2023 and 2033. The market is poised to garner a revenue of USD 37...
Plasma Fractionation Market Revenue to Reach $40.73Bn by 2028 at 6.3% CAGR with Immunoglobulin Segment Driving Growth During 2021–2028 | The Insight Partners
July 13, 2023 09:35 ET
|
The Insight Partners
Pune, India, July 13, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on “Plasma Fractionation Market Revenue Report, Forecast to 2028 – COVID-19 Impact and Global Analysis –...
Albumin (as Excipient) Market to Reach US$ 1.7 Billion by 2031, Driven by a Strong CAGR of 6.3% | Transparency Market Research
June 07, 2023 16:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, June 08, 2023 (GLOBE NEWSWIRE) -- The global albumin (as excipient) market is expected to exceed USD 1.7 Bn by 2031, expanding at a CAGR of 6.3% from 2022 to...